Assessment of Kidney Function and Osteomuscular Status After Critical Care

Launched by UNIVERSITY OF LIEGE · Jul 17, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how critical illness affects kidney function and muscle and bone health in patients who have stayed in the Intensive Care Unit (ICU) for at least seven days. Researchers want to measure kidney function using a special test called iohexol clearance, which gives a direct measurement of how well the kidneys are working. They will also look at other factors like muscle and bone health, to see how these are related to kidney function.

To participate in this study, patients must have survived a critical illness and experienced a specific type of kidney injury while in the ICU. Unfortunately, those with a history of chronic kidney problems, kidney transplants, or certain allergies will not be eligible. If you or someone you know meets these criteria, you can expect to undergo some tests that will help researchers understand how critical illnesses affect health after leaving the ICU. This study aims to improve care for patients recovering from serious health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients surviving an ICU stay of at least 7 days
• • patients who experienced acute kidney injury (KDIGO criteria) during ICU stay
• Exclusion Criteria:
• • chronic kidney injury with dedicated follow-up before ICU admission
• • chronic extrarenal epuration
• • kidney transplant
• • allergy to iohexol
• • iodinated contrast allergy
• • refusal